Insider trades
Stock that executives, directors and 10% owners bought and sold on the open market, from the Form 4s they file with the SEC within two business days. Grants, option exercises and shares sold to cover taxes are left out.
- $1.5B bought by 399 insiders at 253 companies
- $7.2B sold by 412 insiders outside a trading plan
- $3.8B sold by 770 insiders under 10b5-1 plans
- 10 companies where two or more insiders bought (30 days)
Biggest buys
Past 3 months · by insider, all their filings added up
-
LENLennar CorporationBerkshire Hathaway Inc.10% owner · +1 joint filer$595M
-
KODKodiak Sciences IncBaker Bros. Advisors LPDirector · +5 joint filers$157M
-
CRBGCorebridge Financial Inc.Life Insurance Co Nippon10% owner$148M
-
GPIGroup 1 Automotive, Inc.Conifer Management, L.L.C.10% owner$115M
-
UUUUniversal Safety Products, Inc.Milton C Ault IIIDirector$92.5M
-
GMEGameStop CorporationRyan CohenCEO$54M
-
FTKFlotek Industries, Inc.Matthew WilksDirector$34.3M
-
GRABGrab Holdings LimitedAnthony Ping Yeow TanCEO$29.9M
-
GSATGlobalstar, Inc.James Monroe IIIDirector$29.8M
-
COURCoursera, Inc.Pale Fire Capital SE10% owner · +4 joint filers$11.4M
Biggest sales
Past 3 months · by insider, all their filings added up · planned sales marked
-
FANGDiamondback Energy, Inc.SGF FANG Holdings, LP10% owner · +1 joint filer$3.7B
-
IHTInnSuites Hospitality TrustMarc E BergEVP & Secretary/Treasurer$361M
-
NVDANvidia Corporation ComMark A StevensDirector$300M
-
AVGOBroadcom Inc.Henry SamueliDirector$250M
-
CHYMChime Financial, Inc.DST Global Advisors Ltd10% owner · +9 joint filers$232M
-
UMCUnited Microelectronics CorporationChitung LiuCFO$229M
-
LFSTLifeStance Health Group, Inc.Tpg Gp A, LLC10% owner · +2 joint filers$226M
-
THTarget Hospitality Corp.TDR Capital II Investments LP10% owner · +9 joint filers$202M
-
AURAurora Innovation, Inc.Uber Technologies, Inc10% owner$182M
-
DELLDell Technologies Inc.Silver Lake Partners IV, L.P.Director · +4 joint filers$163M
Cluster buying
Companies where two or more insiders bought on the open market in the last 30 days · most buyers first
-
Reuben S Leibowitz Director, Larry C Glasscock Director, Daniel C. Smith Director, Gary M Rodkin Director, +7 more
-
Alexandros Pappas Insider, Raffaele Zagari Director, Symeon Spyrou CFO, Nikolaos Reskos COO, +3 more
-
Daniel L Florness Director, Srilata Zaheer Director, Charles T Lauber Director, Trangsrud Teresa J Rasmussen Director, +3 more
-
Christopher J Abate CEO, Dashiell I Robinson President, Greg H Kubicek Director, Brooke Carillo CFO, +2 more
-
Matthew G De Soto Director, Albert J. Evans Director, Rory G Ritrievi CEO, Kimberly J Brumbaugh Director, +2 more
-
Avenue RP Opportunities Fund, L.P. 10% owner, Par Chadha Director, Avenue Global Opportunities Master Fund LP 10% owner, Andrej Jonovic CEO, +1 more
-
Thomas Jon Hammond Director, Sandip I Patel CFO, John Martin Schaible Chair, David Craig Ridenhour President, +1 more
-
John B Williamson III Director, Robert B Johnston Director, Paul W Nester CEO, Lawrence T. Oliver Senior VP and Secretary, +1 more
-
Kourosh Nasser Zamanizadeh Director, Bessie Ross Wills Director, Nicole Sherman CEO, Stacey Graham Director, +1 more
-
Joseph D Sarafa Director, Brian J Roney CEO, James Grant Smith Director, Harold J Meloche CFO
All insider trades
Newest filings first · one row per filing · every open-market buy and sale
-
Horizon Kinetics Asset Management LLC 10% ownerTPLTexas Pacific Land CorporatiBuy$1,364 4 shares at $340.96 +<0.1% to stakeTraded Sep 29 Filed Oct 1
-
Marta R Stewart DirectorSPGSimon Property Group, Inc.Buy$40K 199 shares at $202.78 +1.1% to stakeTraded Sep 30 Filed Oct 1
-
Daniel C. Smith DirectorSPGSimon Property Group, Inc.Buy$71K 350 shares at $202.78 +1% to stakeTraded Sep 30 Filed Oct 1
-
Stefan M Selig DirectorSPGSimon Property Group, Inc.Buy$42K 208 shares at $202.78 +0.6% to stakeTraded Sep 30 Filed Oct 1
-
Gary M Rodkin DirectorSPGSimon Property Group, Inc.Buy$47K 232 shares at $202.78 +1.1% to stakeTraded Sep 30 Filed Oct 1
-
Randall J Lewis DirectorSPGSimon Property Group, Inc.Buy$13K 65 shares at $202.78 +0.9% to stakeTraded Sep 30 Filed Oct 1
-
Reuben S Leibowitz DirectorSPGSimon Property Group, Inc.Buy$97K 480 shares at $202.78 +0.9% to stakeTraded Sep 30 Filed Oct 1
-
Nina P Jones DirectorSPGSimon Property Group, Inc.Buy$9,328 46 shares at $202.78 +1.1% to stakeTraded Sep 30 Filed Oct 1
-
Larry C Glasscock DirectorSPGSimon Property Group, Inc.Buy$74K 367 shares at $202.78 +0.8% to stakeTraded Sep 30 Filed Oct 1
-
Martin J Cicco DirectorSPGSimon Property Group, Inc.Buy$3,042 15 shares at $202.78 +1.1% to stakeTraded Sep 30 Filed Oct 1
-
Glyn Aeppel DirectorSPGSimon Property Group, Inc.Buy$45K 222 shares at $202.78 +1.1% to stakeTraded Sep 30 Filed Oct 1
-
Alejandro Gustavo Elsztain CEOCRESYCresud S.A.C.I.F. y A.Buy$199K 17,334 shares at $11.50 +1.4% to stakeTraded Sep 30–Oct 1 Filed Oct 1
-
Michael J Happe DirectorFULH. B. Fuller CompanyBuy$99K 2,000 shares at $49.63 +149% to stakeTraded Sep 29 Filed Oct 1
-
Celine Christine Martin DirectorFULH. B. Fuller CompanyBuy$23K 465 shares at $49.50 New stakeTraded Sep 30 Filed Oct 1
-
Francisco Gonzalez CFOSKYHSky Harbour Group CorporationBuy$15K 1,500 shares at $9.69 +0.2% to stakeTraded Sep 30 Filed Oct 1
-
Thomas Patrick Kelly CFOXENEXenon Pharmaceuticals Inc.Buy$560K 15,000 shares at $37.32 New stakeTraded Sep 30 Filed Oct 1
-
Ian Mortimer CEOXENEXenon Pharmaceuticals Inc.Buy$1.1M 30,000 shares at $37.38 +151% to stakeTraded Sep 30 Filed Oct 1
-
Richard Barry CEOFLNAFilana Therapeutics, Inc.Buy$278K 306,813 shares at $0.9100 +30% to stakeTraded Sep 29–30 Filed Oct 1
-
Kun Dai CEOUXINUxin LimitedBuy$9,945 7,443 shares at $1.34 +88% to stakeTraded Sep 30 Filed Oct 1
-
Milton C Ault III Chair · +1 joint filerGPUSHyperscale Data, Inc.Buy$5.1M 10.3M shares at $0.4900Traded Sep 29–30 Filed Oct 1
-
Conifer Management, L.L.C. 10% ownerGPIGroup 1 Automotive, Inc.Buy$66.3M 273,712 shares at $242.15 +17% to stakeTraded Sep 28–30 Filed Sep 30
-
John W. Higuchi DirectorLPCNLipocine Inc.Buy$27K 12,561 shares at $2.16 +6.2% to stakeTraded Sep 28 Filed Sep 30
-
Berkshire Hathaway Inc. 10% owner · +1 joint filerLENLennar CorporationBuy$53.9M 660,410 shares at $81.59Traded Sep 28–30 Filed Sep 30
-
Peter Altman CEOBCDABioCardia, Inc.Buy$1,030 1,000 shares at $1.03 +0.3% to stakeTraded Sep 29 Filed Sep 30
-
Jacob Bistricer COOCLPRClipper Realty Inc.Buy$246K 73,500 shares at $3.35 New stakeTraded Sep 28 Filed Sep 30
-
Paul Seid DirectorINLXIntellinetics, Inc.Buy$948 184 shares at $5.15 +0.1% to stakeTraded Sep 28–30 Filed Sep 30
-
Joshua Horowitz DirectorKWYKingsway CorporationBuy$33K 3,575 shares at $9.26 +0.9% to stakeTraded Sep 28–30 Filed Sep 30
-
William P Scully 10% ownerPRTAProthena Corporation plcBuy$1.4M 162,000 shares at $8.68 +312% to stakeTraded Sep 29 Filed Sep 30
-
Life Insurance Co Nippon 10% ownerCRBGCorebridge Financial Inc.Buy$27.5M 805,782 shares at $34.15 +0.6% to stakeTraded Sep 28 Filed Sep 30
-
Robert Thomas Devincenzi DirectorUTIUniversal Technical Institute IncBuy$20K 1,000 shares at $19.68 +0.7% to stakeTraded Sep 28 Filed Sep 30
-
John Taylor Maloney Fitzgerald CEOKWYKingsway CorporationBuy$2,502 269 shares at $9.30 +<0.1% to stakeTraded Sep 30 Filed Sep 30
-
Kent A Hansen CFOKWYKingsway CorporationBuy$1,572 169 shares at $9.30 +0.1% to stakeTraded Sep 30 Filed Sep 30
-
Sergey Losyev Co-Chief Investment OfficerARRARMOUR Residential REIT, Inc.Buy$10K 725 shares at $13.91 +8.1% to stakeTraded Sep 29 Filed Sep 30
-
Leonard M Tannenbaum DirectorAFCGAdvanced Flower Capital Inc.Buy$344K 95,397 shares at $3.61 +1.4% to stakeTraded Sep 28–30 Filed Sep 30
-
Baker Bros. Advisors LP Director · +5 joint filersKODKodiak Sciences IncBuy$63.4M 715,592 shares at $88.59 +3.7% to stakeTraded Sep 28–29 Filed Sep 30
-
William B. Horne CEOGPUSHyperscale Data, Inc.Buy$16K 100,000 shares at $0.1600 +25% to stakeTraded Sep 30 Filed Sep 30
-
Baker Bros. Advisors LP Director · +5 joint filersKODKodiak Sciences IncBuy$35M 418,323 shares at $83.58 +2.2% to stakeTraded Sep 28 Filed Sep 30
-
Baker Bros. Advisors LP Director · +5 joint filersKODKodiak Sciences IncBuy$58.6M 807,840 shares at $72.57 +4.4% to stakeTraded Sep 28 Filed Sep 30
-
Stanley Frankel DirectorDTILPrecision BioSciences, Inc.Buy$6,000 1,000 shares at $6.00 +2.5% to stakeTraded Sep 28 Filed Sep 30
-
James L Robo DirectorKBDCKayne Anderson BDC, Inc.Buy$1.9M 146,755 shares at $13.03 +24% to stakeTraded Sep 28 Filed Sep 30
-
Richard Barry CEOFLNAFilana Therapeutics, Inc.Buy$78K 93,091 shares at $0.8400 +9.9% to stakeTraded Sep 28 Filed Sep 30
-
Ronald Todd Plott DirectorPHIOPhio Pharmaceuticals Corp.Buy$10K 10,000 shares at $1.04 +31% to stakeTraded Sep 28–29 Filed Sep 30
-
Thomas W Handley DirectorFULH. B. Fuller CompanyBuy$99K 2,000 shares at $49.41 New stakeTraded Sep 28 Filed Sep 30
-
Daniel L Florness DirectorFULH. B. Fuller CompanyBuy$100K 2,030 shares at $49.34 +150% to stakeTraded Sep 28 Filed Sep 30
-
Trangsrud Teresa J Rasmussen DirectorFULH. B. Fuller CompanyBuy$100K 2,042 shares at $48.96 +102% to stakeTraded Sep 28 Filed Sep 30
-
Charles T Lauber DirectorFULH. B. Fuller CompanyBuy$100K 2,005 shares at $49.87 +148% to stakeTraded Sep 29 Filed Sep 30
-
Srilata Zaheer DirectorFULH. B. Fuller CompanyBuy$100K 2,040 shares at $49.08 +152% to stakeTraded Sep 28–29 Filed Sep 30
-
Yair Nechmad ChairNYAXNayax Ltd.Buy$2.1M 46,935 shares at $44.90 +0.6% to stakeTraded Sep 28–29 Filed Sep 30
-
Michael Catelani CFOANIXAnixa Biosciences, Inc.Buy$16K 5,500 shares at $2.84 +12% to stakeTraded Sep 30 Filed Sep 30
-
Robert George Culp IV CEOCULPCulp, Inc.Buy$12K 2,960 shares at $3.89 +2.2% to stakeTraded Sep 28 Filed Sep 30
About this data
- Officers, directors and anyone owning more than 10% of a company must report a trade in its stock on a Form 4 within two business days. We read each filing from SEC EDGAR and link to it on every row.
- Only open-market purchases and sales of common stock count here. Stock grants, option exercises, gifts and shares withheld or sold to pay taxes on vesting awards are not decisions to buy or sell, so they are left out.
- A planned sale was made under a Rule 10b5-1 trading plan, which the insider set up months in advance. Many executives sell this way on a schedule, so a planned sale says less than one made on the day.
- Values are shares times the price reported. When a filing amends an earlier one, the amended trades replace the originals. Related owners (a fund and its manager) who report the same trade separately are shown once.
- We cover the 4,792 US companies on our earnings calendar, with a year of history. The superinvestor notes count the featured 13F managers who added or cut the stock in their latest quarter.